Portal de Periódicos da CAPES

24‐ H our infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced P arkinson's disease

2016; Wiley; Volume: 31; Issue: 4 Linguagem: Inglês

10.1002/mds.26564

1531-8257

Lucia Ricciardi, Francesco Bove, Kristy J. Espay, Francesco Lena, Nicola Modugno, Yu‐Yan Poon, Robert Krikorian, Alberto J. Espay, Alfonso Fasano,

Botulinum Toxin and Related Neurological Disorders

Movement DisordersVolume 31, Issue 4 p. 597-598 Letters: New Observations 24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease Lucia Ricciardi MD, PhD, Lucia Ricciardi MD, PhD Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UKSearch for more papers by this authorFrancesco Bove MD, Francesco Bove MD Istituto di Neurologia, Universitá Cattolica del Sacro Cuore, Rome, ItalySearch for more papers by this authorKristy J. Espay CCRP, Kristy J. Espay CCRP Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USASearch for more papers by this authorFrancesco Lena PT, Francesco Lena PT Neuromed Institute, Pozzilli, IS, ItalySearch for more papers by this authorNicola Modugno MD, PhD, Nicola Modugno MD, PhD Neuromed Institute, Pozzilli, IS, ItalySearch for more papers by this authorYu-Yan Poon RN, Yu-Yan Poon RN Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this authorRobert Krikorian PhD, Robert Krikorian PhD Cognitive Aging Program, Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio, USASearch for more papers by this authorAlberto J. Espay MD, MSc, Alberto J. Espay MD, MSc Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USASearch for more papers by this authorAlfonso Fasano MD, PhD, Corresponding Author Alfonso Fasano MD, PhD Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, CanadaCorrespondence to: Dr. Alfonso Fasano, MD, PhD, Movement Disorders Centre - Toronto Western Hospital, 399 Bathurst St, 7 Mc412, Toronto, ON, Canada M5T 2S8, E-mail: alfonso.fasano@uhn.caSearch for more papers by this author Lucia Ricciardi MD, PhD, Lucia Ricciardi MD, PhD Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UKSearch for more papers by this authorFrancesco Bove MD, Francesco Bove MD Istituto di Neurologia, Universitá Cattolica del Sacro Cuore, Rome, ItalySearch for more papers by this authorKristy J. Espay CCRP, Kristy J. Espay CCRP Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USASearch for more papers by this authorFrancesco Lena PT, Francesco Lena PT Neuromed Institute, Pozzilli, IS, ItalySearch for more papers by this authorNicola Modugno MD, PhD, Nicola Modugno MD, PhD Neuromed Institute, Pozzilli, IS, ItalySearch for more papers by this authorYu-Yan Poon RN, Yu-Yan Poon RN Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this authorRobert Krikorian PhD, Robert Krikorian PhD Cognitive Aging Program, Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio, USASearch for more papers by this authorAlberto J. Espay MD, MSc, Alberto J. Espay MD, MSc Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USASearch for more papers by this authorAlfonso Fasano MD, PhD, Corresponding Author Alfonso Fasano MD, PhD Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, CanadaCorrespondence to: Dr. Alfonso Fasano, MD, PhD, Movement Disorders Centre - Toronto Western Hospital, 399 Bathurst St, 7 Mc412, Toronto, ON, Canada M5T 2S8, E-mail: alfonso.fasano@uhn.caSearch for more papers by this author First published: 04 March 2016 https://doi.org/10.1002/mds.26564Citations: 19 Relevant conflicts of interest/financial disclosures: A.F., N.M., Y.Y.P., K.J.E., and A.J.E. received honoraria (speaker's fees and for participation in advisory boards) from Abbvie, the manufacturer of levodopa/carbidopa intestinal gel. Funding agencies: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume31, Issue4April 2016Pages 597-598 RelatedInformation